Innoviva (INVA) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $1.3.
- Innoviva's EPS (Basic) rose 640000.0% to $1.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.59, marking a year-over-year increase of 2137.4%. This contributed to the annual value of $0.37 for FY2024, which is 8654.55% down from last year.
- Innoviva's EPS (Basic) amounted to $1.3 in Q3 2025, which was up 640000.0% from $1.01 recorded in Q2 2025.
- In the past 5 years, Innoviva's EPS (Basic) ranged from a high of $3.81 in Q3 2022 and a low of -$0.74 during Q1 2025
- Moreover, its 5-year median value for EPS (Basic) was $0.58 (2024), whereas its average is $0.7.
- In the last 5 years, Innoviva's EPS (Basic) plummeted by 285000.0% in 2024 and then soared by 640000.0% in 2025.
- Quarter analysis of 5 years shows Innoviva's EPS (Basic) stood at $1.04 in 2021, then skyrocketed by 266.35% to $3.81 in 2022, then crashed by 66.93% to $1.26 in 2023, then plummeted by 98.41% to $0.02 in 2024, then surged by 6400.0% to $1.3 in 2025.
- Its last three reported values are $1.3 in Q3 2025, $1.01 for Q2 2025, and -$0.74 during Q1 2025.